Tumor Necrosis Factor Receptor 2 Inhibits HIV-1 Infection by Blocking the Binding of gp120 to CD4. [PDF]
Gao Y +8 more
europepmc +1 more source
Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. [PDF]
Singh S, Kumar S, Luthra K.
europepmc +1 more source
From Envelope to Encephalopathy: How HIV-1 gp120 Drives Neurocognitive Decline. [PDF]
Santerre M +4 more
europepmc +1 more source
Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]
Wang H, Yuan J, Wang H.
europepmc +1 more source
Virus particle-based antibody-dependent cellular phagocytosis assay for HIV. [PDF]
Upadhyay C, Rao PG.
europepmc +1 more source
HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane. [PDF]
Quijada-Freire A +15 more
europepmc +1 more source
Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity. [PDF]
Sheik-Khalil E +6 more
europepmc +1 more source
Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill. [PDF]
Wu G +11 more
europepmc +1 more source
HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibition. [PDF]
Myers A +20 more
europepmc +1 more source
Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer. [PDF]
Nawaz FZ +3 more
europepmc +1 more source

